2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Leukemia, Myeloid, Acute
2
Congenital Abnormalities
2
Brain Neoplasms
2
Wilms Tumor
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sezary Syndrome
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Osteosarcoma
1
Neutropenia
1
Neurotoxicity Syndromes
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Interventions
Cyclophosphamide
116
Peripheral Blood Stem Cell Transplantation
96
Filgrastim
73
Etoposide
68
fludarabine phosphate
61
Radiotherapy
58
Rituximab
57
Cyclosporine
49
Mycophenolic Acid
46
Busulfan
44
Melphalan
40
Cytarabine
37
Whole-Body Irradiation
36
Antilymphocyte Serum
35
Tacrolimus
34
Methotrexate
33
Vincristine
27
Methylprednisolone
27
Carmustine
26
Prednisone
24
Doxorubicin
23
sargramostim
20
Cord Blood Stem Cell Transplantation
18
Cisplatin
17
Granulocyte Colony-Stimulating Factor
15
Flow Cytometry
15
Ifosfamide
14
Carboplatin
14
Polymerase Chain Reaction
13
Paclitaxel
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Large-Cell, Immunoblastic
×
Lithium Carbonate
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts